Ecosystem-scale primary production may be proximately limited by nitrogen (N) but ultimately limited by phosphorus (P) because N fixation contributes new N that accumulates relative to P at ecosystem scales. However, the duration needed to transition between proximate N limitation and ultimate P limitation remains unknown for most ecosystems, including lakes. Here we present the results of a fully replicated, multi-annual lake mesocosm experiment that permitted full air-water-sediment interactions that mimicked lake ecosystem ecology. We manipulated N supply relative to P to achieve a gradient of N:P stoichiometry. Despite N fixation contributing as much as 80% of reactive N in the low N treatments, phytoplankton biomass in these treatments was not different from the unfertilized controls. This suggests that primary production remained N limited in the lowest N treatments, even when N fixation was substantial. Although fixed N inputs reduced the N imbalance relative to P in the low N treatments seasonally, fixed N did not accumulate over multiple years. Additionally, reactive N did not readily accumulate in the high N treatments. Instead, water column stoichiometry was proportional to the experimental N and P additions, suggesting a strong influence from external nutrient loading. Thus, we found no evidence that N accumulation from N fixation was sufficient to trigger a transition to ultimate P limitation seasonally or across our 3-year experiment. Rather, our results indicate that proximate N limitation perpetuates in eutrophic lakes, likely due to N export being proportional to its inputs. These findings offer new insight regarding the biogeochemical controls on ecosystem stoichiometry and their influence on the timeframe for proximate N limitation and ultimate P limitation in freshwater, marine, and terrestrial ecosystems.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/ecy.4516 | DOI Listing |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11758711 | PMC |
Comput Biol Med
January 2025
National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, 110067, India. Electronic address:
The biotransformation of drugs by enzymes from the human microbiome can produce active or inactive products, impacting the bioactivity and function of these drugs inside the human host. However, understanding the biotransformation reactions of drug molecules catalyzed by bacterial enzymes in human microbiota is still limited. Hence, to characterize drug utilization capabilities across all the microbial phyla inside the human gut, we have used a knowledge-based approach to develop HgutMgene-Miner software which predicts xenobiotic metabolizing enzymes (XMEs) through genome mining.
View Article and Find Full Text PDFIntegr Psychol Behav Sci
January 2025
Leading Indicator Systems & Motivation Metrics, One Franklin Street, Suite 2508, Boston, MA, 02110, USA.
The concept of human goals is central to the study of psychology (i.e., motivation, behavior, and well-being), sociology (i.
View Article and Find Full Text PDFEur Radiol
January 2025
Department of Radiology, LMU University Hospital, LMU Munich, Marchioninistraße 15, 81377, Munich, Germany.
Objectives: Adenomatous colorectal polyps require endoscopic resection, as opposed to non-adenomatous hyperplastic colorectal polyps. This study aims to evaluate the effect of artificial intelligence (AI)-assisted differentiation of adenomatous and non-adenomatous colorectal polyps at CT colonography on radiologists' therapy management.
Materials And Methods: Five board-certified radiologists evaluated CT colonography images with colorectal polyps of all sizes and morphologies retrospectively and decided whether the depicted polyps required endoscopic resection.
Br J Hosp Med (Lond)
January 2025
Nuffield Department of Primary Health Care Sciences, University of Oxford, Oxford, UK.
The contribution of health care to environmental and climate crises is significant, under-addressed, and with consequences for human health. This editorial is a call to action. Focusing on pharmaceuticals as a major environmental threat, we examine pharmaceutical impacts across their lifecycle, summarising greenhouse gas emissions, pollution, and biodiversity loss, and outlining challenges and opportunities to reduce this impact.
View Article and Find Full Text PDFBr J Hosp Med (Lond)
January 2025
Department of Pediatrics, Taizhou Women and Children's Hospital, Taizhou, Zhejiang, China.
Atopic dermatitis (AD) is a common chronic inflammatory skin disorder globally. Crisaborole, a nonsteroidal topical phosphodiesterase 4 inhibitor (PDE4i), has been utilized in treating AD. Crisaborole regulates the production of inflammatory cytokines, which are usually overactive among AD patients.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!